Anti-oxidant gene therapy by NFκB decoy oligodeoxynucleotide

Current Pharmaceutical Biotechnology

Volumn 7, Issue 2, 2006, Pages 95-100

  Nakagami, Hironori ^a   Tomita, Naruya ^b   Kaneda, Yasufumi ^a   Ogihara, Toshio ^a   Morishita, Ryuichi ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

Cytokine; Endothelial cell; Hyperglycemia; Inflammation; NADPH oxidase; NF B

Indexed keywords

ANTIOXIDANT; ANTISENSE OLIGODEOXYNUCLEOTIDE; ASCOMYCIN; CASPASE; CELL ADHESION MOLECULE; CORTICOSTEROID; CYTOKINE; EXONUCLEASE; GLUCOSE; HYDROGEN PEROXIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MYC PROTEIN; NITRIC OXIDE; OLIGODEOXYNUCLEOTIDE; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BCL 2; PROTEIN KINASE B; PROTEIN KINASE C; PROTEINASE; RAC PROTEIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SCATTER FACTOR; SUPEROXIDE; TACROLIMUS;

APOPTOSIS; ARTERIOSCLEROSIS; ARTERY INTIMA PROLIFERATION; ATHEROGENESIS; ATHEROSCLEROSIS; ATOPIC DERMATITIS; CARDIOVASCULAR DISEASE; CELL TRANSPORT; CLINICAL TRIAL; CORONARY ARTERY; CORONARY RISK; DIABETIC PATIENT; DISEASE COURSE; DRUG DEGRADATION; DRUG SYNTHESIS; DRUG TRANSPORT; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVATION; GENE TARGETING; GENE THERAPY; GENETIC TRANSFECTION; GLOMERULONEPHRITIS; HEART PROTECTION; HUMAN; HYPERGLYCEMIA; ISCHEMIC HEART DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OSTEOPOROSIS; OXIDATIVE STRESS; PATHOGENESIS; PROMOTER REGION; PROTEIN EXPRESSION; RESTENOSIS; REVIEW; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; RISK FACTOR; STROKE; TRANSACTIVATION; UNSPECIFIED SIDE EFFECT; UPREGULATION; VASCULAR DISEASE;

ANIMALS; ANTIOXIDANTS; GENE THERAPY; HUMANS; HYPERGLYCEMIA; OLIGODEOXYRIBONUCLEOTIDES;

SUIDAE;

EID: 33746382516     PISSN: 13892010     EISSN: None     Source Type: Journal    
DOI: 10.2174/138920106776597702     Document Type: Review

References (39)

1. Billups, K.L.; Palladino. M.A.; Hinton, B.T. and Sherley, J.L. (1995) J. Lab. Clin. Med. 125, 626-633.
2. Kukielka, G.L.; Smith, C.W.; Manning, A.M.; Youker, K.A.; Michael, L.H. and Entman M.L. (1995) Circulation 92, 1866-1875.
3. Oz, M.C.; Liao, H.; Naka, Y.; Seldomridge, A.; Beekerm, D.N.; Michler, R.E.; Smith, C.R.; Rose, E.A.; Stern, D.M. and Pinsky, D.J. (1995) Circulation 92(suppl II), 428-432.
4. Herskowitz. A.; Choi, S.; Ansari A.A. and Wesselingh, S. (1995) Am. J. Pathol. 146, 419-428.
5. Youker, K.A.; Hawkins, H.K.; Kukielka, G.L.; Perrard, J.L.; Michael, L.H.; Ballantyne, C.M.; Smith, C.W. and Entman M.L. (1994) Circulation 89, 2736-2746.
6. Lenardo, M.J. and Baltimore, D. (1999) Cell 58, 227-229.
7. Morishita, R.; Sugimoto. T.; Aoki, M.; Kida, I.; Tomita, N.; Moriguchi, A.; Maeda, K.; Sawa, Y.; Kameda, Y.; Higaki, J. and Ogihara T. (1997) Nat Med 3. 894-899.
8. Sawa, Y.; Morishita. R.; Suzuki, K.; Kagisaki, K.; Kaneda. Y.; Maeda, K.; Kadoba K. and Matsuda, H. (1997) Circulation 965, 280-285.
9. Suzuki, J.; Morishita, R.; Amano. J.; Kaneda. Y. and Isobe, M. (2000) Gene Ther. 7, 1847-1852.
10. Yokoseki, O.; Suzuki. J.; Kitabayashi, H.; Watanabe, N.; Wada. Y.; Aoki, M.; Morishita, R.; Kaneda, Y.; Ogihara, T.; Futamatsu H.; Kobayashi, Y. and Isobe, M. (2001) Circ. Res. 89, 899-906.
11. Gibbons, G.H. and Dzau, V.J. (1994) N. Engl. J. Med. 330, 1431-1438.
12. Simons, M.; Edelman, E.R.; DeKeyser, J.-L.; Langer, R. and Rosenberg, R.D. (1992) Nature 359, 67-90.
13. Shi, Y.; Fard, A.; Gateo, A.; Hutchinson, H.G.; Vermami, P.; Dodge, G.R.; Hall, D.J.; Shaheen, F. and Zalewski, A. (1994). Circulation 90, 944-951.
14. Kutryk, M.J.; Foley, D.P.; van den Brand, M.; Hamburger, J.N.; van der Giessen, W.J.; deFeyter, P.J.; Bruining, N.; Sabate, M. and Serruys, P.W. (2002) J. Am. Coll. Cardiol. 39, 281-297.
15. Yoshimura, S.; Morishita, R.; Hayashi, K.; Yamamoto, K.; Nakagami, H.; Kameda, Y.; Sakai, N. and Ogihara, T. I(2001) Gene Ther. 8. 1635-1642.
16. Yamasaki, K.; Asai, T.; Shimizu. M.; Aoki, M.; Hashiya, N.; Sakonjo, H.; Makino. H.; Kaneda, Y.; Ogihara, T. and Morishita, R. (2003) Gene Ther. 10, 356-364.
17. Matsushita. H.; Morishita, R.; Nata. T.; Aoki, M.; Nakagami, H.; Taniyama, Y.; Yamamoto, K.; Higaki, J.; Kaneda Y. and Ogihara, T. (2000) Circ. Res. 86, 974-981.
18. Tomita. N.; Morishita, R.; Tomita. S.; Kaneda, Y.; Higaki, J.; Ogihara, T. and Horiuchi, M. (2001) Exp. Nephrol. 9, 181-190.
19. Tomita. N.; Morishita, R.; Tomita. S.; Gibbons, G.H.; Zhang, L.; Horiuchi, M.; Kaneda. Y.; Higaki, J.; Ogihara, T. and Dzau, V.J. (2000) Gene Ther. 7, 1326-1332.
20. Tomita, N.; Morishita, R.; Lan, H.Y.; Yamamoto. K.; Hashizame. M.; Notakae. M.; Toyosawa. K.; Fujitan, B.; Mu, W.; Nikolic-Paterson, D.J.; Atkins, R.C.; Kaneda, Y.; Higaki, J. and Ogihara T. (2000) J. Am. Soc. Nephrol. 11, 1244-1252.
21. Azuma. H.; Tomita, N.; Kaneda, Y.; Koike, H.; Ogihara, T.; Katsuoka Y. and Morishita, R. (2003) Gene Ther. 10, 415-425.
22. Tomita, T.; Takano, H.; Tomita. N.; Morishita, R.; Kaneko. M.; Shi, K.; Takahi, K.; Nakase, T.; Kaneda, Y.; Yoshikawa, H. and T. Ochi, T. (2000) Rheumatology (Oxford) 39, 749-757.
23. Tomita, T.; Takeuchi, E.; Tomita, N.; Morishita, R.; Kaneko, M.; Yamamoto. K.; Nakese. T.; Seki, H.; Kato, K.; Kaneda, Y. and Ochi, T. (1999) Arthritis Rheum 42, 2532-2542.
24. Nakamura, H.; Aoki, M.; Tamai, K.; Oishi, M.; Ogihara, T.; Kaneda, Y. and Morishita, R. (2002). Gene Ther. 9, 1221-1229.
25. Roque, F.; Mon, G.; Belardi, J.; Rodriguez, A.; Grinfeld, L.; Long, R.; Grossman, S.; Malcolm, A.; Zon, G.; Ormont, M.L.; Fischman, D.L.; Shi, Y. and Zalewski, A. (2001) Antisense. Nucl. Acid Drug Dev. 11, 99-106.
26. Shimizu, H.; Nakagami, H.; Tsukamoto, L; Morita, S.; Kunugiza, Y.; Tomita, T.; Yoshikawa. H.; Kaneda, Y.; Ogihara, T. and Morishita, R. (2006) Gene Ther. (in press).
27. Kaneda, Y.; Nakajima, T.; Nishikawa, T.; Yamamoto, S.; Ikegami, H.; Suzuki, N., Nakamura, H.; Morishita, R. and Kotani, T. (2002) Mol. Ther. 6, 219-226.
28. Gibson, I. (1996) Cancer Metastasis Rev. 15, 287-299.
29. Khaled, Z.; Benimetskaya, L.; Zeltser. R.; Khan, T.; Sharma, H.W.; Narayanan. R. and Stein, C.A. (1996) Nucl. Acids Res. 24, 737-775.
30. Henry, S.P.; Bolte. H.; Auletta, C. and Kornbrust, D.J. (1997) Toxicology 120, 145-155.
31. Burgess, T.L.; Fisher, E.F.; Ross, S.L.; Bready, J.V.; Qian, Y.X.; Bayewitch, L.A.; Cohen, A.M.; Herrera, C.J.; Hu, S.S.; Kramer, T.B.; Lott, F.D.; Martin. D.H.; Pierce. G.F.; Simonet, L. and Farrell, C.L. (1995) Proc. Natl. Acad Sci. USA 92, 4051-4055.
32. Srinivasan, S.K. and Iversen, P. (1995) J. Clin. Lab. Anal. 9, 129-137.
33. Cornish, K.G.; Iversen, P.; Smith. L.; Arneson, M. and Bayever, E. (1993) Pharmacol, Res. Commun. 3, 239.
34. Henry, S.P.; Giclas, P.C.; Leeds, J.; Pangburn, M.; Auletta, C.; Levin, A.A. and Kornbrust, D.J. (1997) J. Pharmacol. Exp. Ther. 281, 810-816.
35. Crooke, S.T. (1995) Hematol. Pathol, 9, 59-72.
36. Ahn. J.D.; Morishita. R.; Kaneda, Y.; Lee, S.J.; Kwon, K.Y.; Choi.; S.Y.; Lee, K.U.; Park, J.Y.; Moon, I.J.; Park, J.G.; Yoshizumi, M., Ouchi. Y. and Lee, L.K. (2002) Circ. Res. 90, 1325-1332.
37. Chu, B.C.F. and Orgal, L. (1992) Nucl. Acids Res. 20, 5957-5959.
38. Abe, T.; Takai, K.; Nakada, S.; Yokota, T. and Takaku, H. (1998) FEBS Lett. 425, 91-96.
39. Ahn, J.D.; Morishita, R.; Kaneda, Y.; Kim, H.S.; Chang, Y.C.; Lee, K.U.; Park, J.Y.; Lee, H.W.; Kim, Y.H. and Lee, I.K. (2002) Gene Ther. 9, 1692-1692.